SCHEMBL22481561

SCHEMBL22481561

CN(C(=O)CCl)c1nccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.48
NR3C1 P04150 1/20 0.41
ALDH1A1 P00352 5/20 0.39
GSK3B P49841 1/20 0.39
TRPM8 Q7Z2W7 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
PKM P14618 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 3/20 0.34
HTT P42858 2/20 0.34
HTR7 P34969 1/20 0.34
KMT2A Q03164 1/20 0.34
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13545685 0.84 FFAR2 (0.46) FFAR2NR3C1ALDH1A1TRPM8SMN1; SMN2
SCHEMBL2936251 0.82 FFAR2 (0.49) FFAR2NR3C1ALDH1A1GSK3BTRPM8
SCHEMBL9942595 0.81 FFAR2 (0.44) FFAR2NR3C1ALDH1A1TRPM8SMN1; SMN2
SCHEMBL972961 0.80 FFAR2 (0.43) FFAR2NR3C1ALDH1A1TRPM8SMN1; SMN2
SCHEMBL18969622 0.80 FFAR2 (0.43) FFAR2NR3C1ALDH1A1TRPM8PKM
SCHEMBL30088848 0.79 ALDH1A1 (0.43) FFAR2NR3C1ALDH1A1TRPM8SMN1; SMN2
SCHEMBL14591145 0.78 FFAR2 (0.49) FFAR2NR3C1ALDH1A1TRPM8SMN1; SMN2
SCHEMBL13359498 0.77 FFAR2 (0.48) FFAR2NR3C1ALDH1A1TRPM8SMN1; SMN2
SCHEMBL13585397 0.75 FFAR2 (0.42) FFAR2NR3C1ALDH1A1TRPM8PKM
SCHEMBL27872396 0.75 FFAR2 (0.42) FFAR2NR3C1ALDH1A1TRPM8PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332459-B2 Benzimidazole derivatives and their uses TEIJIN PHARMA LIMITED (JP) 2022-05-17 US disclosed
US-20200308145-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USES AMGEN INC. (US) 2020-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200308145-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USES TRPC6, TRPV6, TRPM6 FFAR2 923/4885NR3C1 4187/4885ALDH1A1 1564/4885
US-11332459-B2 Benzimidazole derivatives and their uses TRPC6, TRPV6, TRPM6 FFAR2 923/4885NR3C1 4187/4885ALDH1A1 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.